The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
The company is now introducing the product into the India pharmaceutical market.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease
Subscribe To Our Newsletter & Stay Updated
